RecruitingNot ApplicableNCT06261671

Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.

Antioxidants-enriched Single-step vs Global Total Single-step Embryo Culture Media: Effect on Blastocyst Euploidy Rates.

Sponsor

ART Fertility Clinics LLC

Enrollment

500 participants

Start Date

Feb 1, 2024

Study Type

INTERVENTIONAL

Conditions

Infertility In-Vitro Fertilization

Summary

One of the most sensible factors in IVF culture conditions is the susceptibility of gametes and embryos to an induced increase in reactive oxidative species (ROS) caused by the artificial environment. This study aims to evaluate the impact of using antioxidant-supplemented media during culture to evaluate embryo ploidy rates in a prospective randomized trial using sibling oocytes.

Eligibility

Min Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called antioxidants-enriched culture medium (Gx) for people with in-vitro fertilization and infertility. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 43 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGantioxidants-enriched culture medium (Gx)

Blastocyst will be in continuous culture conditions (parallel antioxidants-enriched culture medium (Gx) and Global total one step media (GT) without refreshment on day 3. A refreshment of the media will be done on D5 in both groups.